COMMUNIQUÉS West-GlobeNewswire

IBA SA : IBA signs contract with China CNNR to install Proteus®ONE solution in China

29/05/2018 - 07:03

IBA signs contract with China CNNR to install Proteus ® ONE solution in China Contract worth between EUR 35 and 40 million Louvain-la-Neuve, Belgium, 29 May 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world's [...]

IBA SA : IBA signe un contrat avec China CNNR pour l'installation d'une solution Proteus®ONE en Chine

29/05/2018 - 07:03

IBA signe un contrat avec China CNNR pour l'installation d'une solution Proteus®ONE en Chine Valeur du contrat estimée entre EUR 35 et 40 millions Louvain-la-Neuve, Belgique, 29 mai 2018 - IBA ( Ion Beam Applications SA [...]

Biocartis Group NV: Disclosure of a transparency notification

29/05/2018 - 07:01

PRESS RELEASE: REGULATED INFORMATION 29 May 2018, 07:00 CEST Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Mechelen, Belgium, [...]

Orphazyme Capital Markets Day 2018 – from Biology to Bedside

29/05/2018 - 06:05

Orphazyme A/S Company announcement No. 06/2018 Copenhagen, May 29, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, announces that a Capital [...]

Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.

29/05/2018 - 00:00

Creates Premier Women’s Health Business Unit in High Growth Genetic Testing Market SALT LAKE CITY, May 28, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and [...]

Nova Leap Health Corp. Reports First Quarter 2018 Financial Results and Provides Corporate Update

28/05/2018 - 23:18

HALIFAX, Nova Scotia, May 28, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or “the Company”), a company [...]

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

28/05/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - May 28, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

Cannabis Wheaton Income Corp. Streaming Partner FSD Pharma Inc. to Commence Trading on CSE Under Symbol “HUGE”

28/05/2018 - 21:17

VANCOUVER, British Columbia, May 28, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) (" Cannabis Wheaton " or the " Company ") is pleased to announce that its previously announced streaming partner [...]

AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis

28/05/2018 - 18:24

Paris, May 28, 2018, 6.15pm AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis AB Science SA (NYSE Euronext - FR0010557264 - AB), a [...]

AB Science fait le point sur la demande d'autorisation de mise sur le marché du masitinib dans le traitement de la sclérose latérale amyotrophique

28/05/2018 - 18:24

Paris, 28 mai 2018, 18h15 AB Science fait le point sur la demande d'autorisation de mise sur le marché du masitinib dans le traitement de la sclérose latérale amyotrophique AB Science SA (NYSE Euronext - FR0010557264 - [...]

Ossur Hf :Transactions in relation to share buyback program

28/05/2018 - 18:01

Announcement no. 37/2018 Reykjavik, 28 May 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

NÉOVACS : COMPTE-RENDU ASSEMBLÉE GÉNÉRALE ANNUELLE 2018

28/05/2018 - 18:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE COMPTE-RENDU ASSEMBL É E G É N É RALE ANNUELLE 2018 ACTIVATION DE LA DERNI È RE TRANCHE DE LA LIGNE DE FINANCEMENT EN FONDS PROPRES EXISTANTE, [...]

Share buy-back week 21/2018

28/05/2018 - 16:41

Announcement 28 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Novartis International AG: Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®

28/05/2018 - 16:31

Overall summary score was also significantly higher for Entresto patients than for patients not taking Entresto, as measured by the 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12)[1] These improvements were [...]

Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2018

28/05/2018 - 15:01

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 28, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial [...]

Novo Nordisk A/S - Share repurchase programme

28/05/2018 - 12:52

Bagsværd, Denmark, 28 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia

28/05/2018 - 11:20

Company Announcement - No. 16/2018 Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia Last patient visit concluded in the multinational [...]

Mandatory notification of trade

28/05/2018 - 10:42

Reference is made to the announcement today from Vistin Pharma ASA ("Vistin Pharma") regarding the final result of the subsequent repair issue. Vegard Heggem, VP Operations, has been allocated 10,000 new shares at a [...]

Transactions under Novozymes’ stock buyback program

28/05/2018 - 10:34

Please read the full announcement in the attached PDF Attachment 2018_36_Stock_Buybackprogram_EN